Mucosal immunology Virology

The global cancer immunotherapies market reached $30.8 billion in 2012. This market is expected to grow to nearly $34.3 billion in 2013 and $67.9 billion in 2018 with a compound annual growth rate (CAGR) of 14.7% over the five-year period, 2013 to 2018.

 

Immunotherapy can be defined as the Treatment to stimulate or restore the ability of the immune (defence) system to fight infection and disease. Biological therapy is thus any form of treatment that uses the body's natural abilities that constitute the immune system to fight infection and disease or to protect the body from some of the side effects of treatment. Chemotherapy and radiation therapy are two of the most effective treatment approaches for cancer

Monoclonal antibodies are used to treat many diseases, including some types of cancer. To make a monoclonal antibody, researchers first have to identify the right antigen to attack. Acquired resistance is said to occur when a particular microorganism obtains the ability to resist the activity of a particular antimicrobial agent to which it was previously susceptible. This can result from the mutation of genes involved in normal physiological processes and cellular structures, from the acquisition of foreign resistance genes or from a combination of these two mechanisms.   

  • Chemotherapy
  • Radiotherapy
  • Cellular immunotherapy
  • Cancer immunotherapy
  • Antibody therapy
  • Cytokine therapy
  • Immune system stimulation
  • Acquired resistance

Related Conference of Mucosal immunology Virology

Mucosal immunology Virology Conference Speakers